Clinical Trial Update: Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1) [NA]

View source ↗

Summary

The clinical trial evaluating butyrate and palmitoylethanolamide for irritable bowel syndrome with diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Butyrate (butyrate)
• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: University of Padova | Conditions: Irritable Bowel Syndrome With Diarrhea | NA | Status: COMPLETED